India, situated in the southern part of Asia, attained its independence in 1947. A complex nation with a rich ancient culture and an ultra-hip western style -from farmers committing suicide due to poverty, to Learjetting tycoons. A Developed India by 2020 is the vision. It has the world's second largest population with 1.1 billion people -now, turning into an asset -compared with the United Kingdom with 60.2 million and the United States of America with 300 million. Gross domestic product (GDP) per capita (Intl $, 2004) is 1830 (cf: USA -39 901, UK-31 308). 1 The health sector in India is characterized by: 1) a fee-levying private sector that plays the dominant role in the provision of individual care; and accounts for 82% of the overall health expenditure and 4.2% of the GDP. Financed from private resources, it places a disproportionate burden on the poor -with medical insurance yet to take off, 2) a government sector, that provides publicly financed and managed -primary to tertiary level -health services, throughout the countryfree of cost (accounts for only 18% of the overall health spending and 0.9% of GDP). For the period 1998, the total health expenditure as a percentage of the GDP was 5.1% (2003: 4.8%) is about one-third that of USA.
The total government health expenditure as a percentage of the total government expenditure was 5.6%. 2 India has the largest private health sector in the world, which is used by both rural and urban patients. Traditional, indigenous systems of medicine, namely, Siddha, Ayurverda, Unani flourish in the more rural areas; along with Homeopathy.
India remains one of the lowest public-health spending countries in the world. 3 Though the total number of physicians is 645 825 (cf: USA 730 801, UK 133 841), physician density per 1000 population is low 0.60 (cf: USA 2.56, UK 2.30). Similarly a poor picture is reflected in life-expectancy at birth being low and child and adult mortality rates high. 1 Presently, key health indicators paint a gloomy picture, mainly because of the low literacy rate of around 65% (cf: UK 99%), of a 75% rural population, 25% of them living below the poverty line and coupled with political apathy. There is a definite divide between the urban, elite, state-of-the-art (mostly private) healthcare and an insufficient, pathetic delivery of govermental health-care to the poor 820 million rural population! This is compounded by a lack of infrastructure and manpower.
Individual, independent entrepreneurs have created multiple, urban centres of excellence in every field of medicine at par with international standards; and that includes respiratory medicine. Apollo is the largest private healthcare provider in Asia and the third largest in the world; among the first in India to be accredited by the USA-based Joint Commission International. 4 Rural hospitals have many problems, but urban hospitals are equipped with high-quality medical equipment and devices, and many doctors possess high level professional qualifications. Patients come to these hospitals not only from across India, but also from around the world -the reason for the expanding medical tourism here.
Respiratory medicine was looked upon predominantly as a Tuberculosis (TB) speciality. Early in the 1990s, with the advent of the fibreoptic bronchoscope and computerized tomographic chest scans, respiratory medicine surged ahead to become a superspeciality; with the entire spectrum of non-tuberculous diseases being diagnosed, presently. The wide range of interventional procedures from video-assisted 8 The national TB programme started in 1962, created an infrastructure for TB control throughout the country. The National college of chest physicians (earlier known as Indian association for chest diseases since 1959) was formed in 1981, has 938 members. 9 and the Indian Chest Society formed in 1980 and has 1101 members. 10 The Indian Association of Bronchology was started in 1995, has about 300 members. 11 Key findings from the TRC and NTI have changed TB treatment practices all over the world. The mass-BCG-campaign was started in 1951. From 1955 to 1958, India conducted a national TB survey, documenting the burden and need for a tuberculosis control programme. In 1956, TRC studied the application of mass domiciliary chemotherapy for pulmonary TB, without any additional risk to the contacts. It was also proved that intermittent chemotherapy was as effective as daily treatment -a forerunner for directly observed treatment, short-course (DOTS). In 1968, the Indian government carried out the Chingleput BCG vaccination trial. It revealed that though BCG did not offer protection against bacillary form of pulmonary TB, it did protect against the serious childhood forms of TB. Short course chemotherapy regimens were started with inputs from trials conducted at TRC from 1983 to 1986 along with NTI. [16] [17] [18] [19] [20] [21] [22] TRC has valuable data on extrapulmonary TB.
India is going through a period of transition. Infectious diseases are still persisting as major health problems in spite of having national programmes, amongst people of the lower socio-economic group. According to 1998 estimates, non-communicablediseases are responsible for 32% of all deaths in the country of which chronic respiratory diseases contribute 6.7%. 3 The government national health programmes has TB among the 10 main programmes, by the department of health. 23 In India, TB accounts for more adult deaths than any other infectious disease (one every minute). Globally, one-fifth of new TB cases are from India every year. TB is the most common opportunistic infection in people with Human Immunodeficiency Virus (HIV). 24 Further, it is a major barrier to economic development, costing India approximately US $3 billion a year. 16 TB is no ordinary epidemic, but a sensitive indicator of socio-economic status. 25 The National Tuberculosis Programme started in 1962, had not achieved the desired results. Hence, since 1993, DOTS had been pilot tested in India as the Revised National Tuberculosis Control Programme (RNTCP) and launched in 1997. The principles of modern TB control, first developed in India, in the 1950s had travelled around the world and finally returned home, nearly 40 years later as DOTS. RNTCP has been implemented nationwide. 26 Presently World Health Organization (WHO) reports TB incidence and prevalence (all cases/100 000 population) at 168 and 312 respectively, and mortality (deaths/100 000 population/year) at 30. New multidrug-resistant TB (MDR-TB) cases are 2.4%. 27 HIV seropositivity among MDR-TB is 4.7%. 28 Guidelines for the management of Bronchial asthma and Chronic obstructive pulmonary disease (COPD) and TB in special situations have been developed. [29] [30] [31] The overall prevalence of asthma is 2.38% over 15 years of age, translates into an enormous national burden of over 24 million. The prevalence of one or more respiratory symptoms (including wheezing) was 4.3-10.5%. 32 Usage of inhalers is poor and the message is spreading. Similarly, COPD was diagnosed in 4.1% of subjects over 30 years of age, 5% in males and 3.2% in females with a smoker to nonsmoker ratio of 2.65 : 1. Prevalence among bidi (handrolled form of tobacco, wrapped in dried tendu leaves) and cigarette smokers was 8.2% and 5.9%. 33 Environmental tobacco smoke exposure during childhood is an important risk factor for asthma and respiratory symptoms in non-smoking adults. 34 The prevalence of smoking is 28.5% in men and 2.1% in women. Bidi is the commonest form of smoking, more so in the rural areas. The number of cigarettes/bidis smoked per day was 14 (Ϯ11.5) and age of starting about 20.5 years. Increasing age, low socio-economic status and rural residence were important factors associated with smoking. The quit-rate of 10% is low, in spite of the various anti-tobacco measures. There is a significant respiratory morbidity associated with smoking. 35 Biomass fuel is used for cooking with poor ventilation contributes to chronic bronchitis. Good ventilation diminishes the adverse effect on lung functions. 36 There are only a few studies with established reference standards for Pulmonary function of Indian children, in comparison with more than 120 western reference standards. 37 Peak expiratory flow rate assessment though have many Indian studies. 38 India is one of the first countries in the world, to ban smoking in public places -including air travel.
Recent industrialization and globalizations are changing the Indian occupational morbidity drastically. Traditionally labor-oriented markets are on change towards more automation and mechanization; at the same time general awareness about occupational safety, is not spread in the society. This includes child labor, poor industrial legislation, vast informal sector, less attention to industrial hygiene and poor surveillance data across the country. An estimated 70-115 million children are part of Indian work force. Overall prevalence of pneumoconiosis is about 3% and Asbestosis is present. More than 20 million workers are involved in the textile industry; studies show 30% had byssinosis. Inhalation of sulfur dust causes respiratory infections, asthma, eye infections and other chronic lung diseases. 39 The methyl isocyanate (MIC) gas leak from the Union Carbide plant, at Bhopal, India, in 1984, was the worst industrial disaster in history. Of the 200 000 persons exposed, more than 6000 deaths have resulted, and about 50 000 persons are estimated to be suffering from long-term health-effects, mainly chronic inflammatory damage to the eyes and lungs . 40 Urban air pollution could be responsible for about 40 000 premature deaths annually, primarily due to human exposure to elevated levels of particulate matter. 41 Relative proportion of lung cancer as a percentage of all sites (averaged figures) in males, is about 7-11% and in females 1.4-1.9%; and for pleura in males about 0.05% and in females 0.03% respectively. 42, 43 India has not reported any human cases of avian influenza. 44 Or severe acute respiratory syndrome (2003) 45 although there were a few unauthenticated reports. Sarcoidosis, Interstitial lung diseases, and so on, and other rarer respiratory illnesses are diagnosed on a routine basis.
Research is relegated to few institutions. Few breakthroughs have been done with the exception of Dr AS Paintal's discovery of the lung deflation receptors, the domiciliary treatment for TB, the extrapulmonary beneficial effects of BCG vaccination and contribution to DOTS. 16, 17, 19, 22, 46 The first disease management programme (DMP) in India, amongst all medical specialities, was launched in Bronchial Asthma in 2003. It is being successfully run (by this author at this institute) in the name of 'BreatheEazy Clinic', as a pioneering effort. This forms the anchor for other DMP programmes in other specialities, in the country, to follow; and has enrolled about 3200 patients to date.
Conclusion
Lung health includes medical care and an interdisciplinary, multi-sectoral, private-governmental partnership of health care that permeates to all segments of people, rich or poor. Only then, will the gross disparity in health be ameliorated. The Government of India, Ministry of Health and Family Welfare, has to percolate the achievements of the tertiary-care urban institutions, to the primary-care rural areas, which is where real India lies. The roadmap is set. Respiratory Medicine is developed to be on par with the world in diagnosis and treatment, but lags behind in research. It is, as in other healthcare sections, the duty of the government to lead. National medical insurance may be the answer and political drive will be mandatory.
